<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27325702</article-id>
<article-id pub-id-type="pmc">5016122</article-id>
<article-id pub-id-type="publisher-id">M116.733626</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.733626</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Bases of Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4<sup>CRBN</sup> and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">Modulation of E3 Ligases by APP</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1168-6864</contrib-id>
<name>
<surname>Del Prete</surname>
<given-names>Dolores</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rice</surname>
<given-names>Richard C.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-8161-6701</contrib-id>
<name>
<surname>Rajadhyaksha</surname>
<given-names>Anjali M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9820-4882</contrib-id>
<name>
<surname>D'Adamio</surname>
<given-names>Luciano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461 and </aff>
<aff id="aff2">the <label>§</label>Division of Pediatric Neurology, Department of Pediatrics, and </aff>
<aff id="aff3"><label>¶</label>Feil Family Brain and Mind Research Institute, Weill Cornell Autism Research Program, Weill Cornell Medical College, New York, New York 10065</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed. E-mail: <email>luciano.dadamio@einstein.yu.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>12</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>291</volume>
<issue>33</issue>
<fpage>17209</fpage>
<lpage>17227</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc03316017209.pdf"></self-uri>
<abstract>
<p>The amyloid precursor protein (APP), whose mutations cause Alzheimer disease, plays an important <italic>in vivo</italic> role and facilitates transmitter release. Because the APP cytosolic region (ACR) is essential for these functions, we have characterized its brain interactome. We found that the ACR interacts with proteins that regulate the ubiquitin-proteasome system, predominantly with the E3 ubiquitin-protein ligases Stub1, which binds the NH<sub>2</sub> terminus of the ACR, and CRL4<sup>CRBN</sup>, which is formed by Cul4a/b, Ddb1, and Crbn, and interacts with the COOH terminus of the ACR via Crbn. APP shares essential functions with APP-like protein-2 (APLP2) but not APP-like protein-1 (APLP1). Noteworthy, APLP2, but not APLP1, interacts with Stub1 and CRL4<sup>CRBN</sup>, pointing to a functional pathway shared only by APP and APLP2. <italic>In vitro</italic> ubiquitination/ubiquitome analysis indicates that these E3 ligases are enzymatically active and ubiquitinate the ACR residues Lys<sup>649/650/651/676/688</sup>. Deletion of Crbn reduces ubiquitination of Lys<sup>676</sup> suggesting that Lys<sup>676</sup> is physiologically ubiquitinated by CRL4<sup>CRBN</sup>. The ACR facilitated <italic>in vitro</italic> ubiquitination of presynaptic proteins that regulate exocytosis, suggesting a mechanism by which APP tunes transmitter release. Other dementia-related proteins, namely Tau and apoE, interact with and are ubiquitinated via the ACR <italic>in vitro</italic>. This, and the evidence that CRBN and CUL4B are linked to intellectual disability, prompts us to hypothesize a pathogenic mechanism, in which APP acts as a modulator of E3 ubiquitin-protein ligase(s), shared by distinct neuronal disorders. The well described accumulation of ubiquitinated protein inclusions in neurodegenerative diseases and the link between the ubiquitin-proteasome system and neurodegeneration make this concept plausible.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer disease</kwd>
<kwd>amyloid precursor protein (APP)</kwd>
<kwd>E3 ubiquitin ligase</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>ubiquitylation (ubiquitination)</kwd>
<kwd>CRL4CRBN</kwd>
<kwd>Cereblon</kwd>
<kwd>Intellectual disability</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>National Institute on Aging
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000049</named-content></funding-source>
<award-id>R01AG033007</award-id>
<award-id>R01AG041531</award-id>
<award-id>R21AG048971</award-id>
<award-id>R01AG052286</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>